Abbott completes enrollment in preventive cardiac-care study

By Elaine Rigoli

Tampa, Fla., Aug. 30 - Abbott Vascular said it has completed enrollment in a landmark study designed to increase clinical understanding of "vulnerable" plaque - a lipid-rich coronary plaque that suddenly ruptures - believed to be the cause of most heart attacks.

The study enrolled 700 acute coronary syndrome patients receiving stents in the United States and Europe. Patients will be followed for as many as five years.

The company said the study uses novel intravascular imaging technology to correlate plaque characteristics, patient risk factors and biomarker measurements with subsequent heart attacks and other cardiac events, potentially paving the way for physicians to identify and treat at-risk patients before a heart attack occurs.

Abbott Vascular, a division of Abbott, is based in Temecula, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.